
pmid: 7913385
handle: 2434/209288 , 11381/2839210
β-blockers; calcium antagonists; lactosaminated Fab; LDL receptors, Adrenergic beta-Antagonists, Hypercholesterolemia, Calcium Channel Blockers, Bile Acids and Salts, Lipoproteins, LDL, Immunoglobulin Fab Fragments, Receptors, LDL, Animals, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Skin
β-blockers; calcium antagonists; lactosaminated Fab; LDL receptors, Adrenergic beta-Antagonists, Hypercholesterolemia, Calcium Channel Blockers, Bile Acids and Salts, Lipoproteins, LDL, Immunoglobulin Fab Fragments, Receptors, LDL, Animals, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Skin
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 0 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
